New Dexcom CEO wants you to wear a glucose monitor

Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with Type 2 diabetes and ...
Yahoo Finance

Investors in DexCom (NASDAQ:DXCM) have unfortunately lost 43% over the last three years

DexCom, Inc. (NASDAQ:DXCM) shareholders should be happy to see the share price up 12% in the last month. But that doesn't help the fact that the three year return is less impressive. In fact, the ...
Hosted on MSN

Citigroup maintains DexCom (DXCM) buy recommendation

Fintel reports that on December 11, 2025, Citigroup maintained coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation. Analyst Price Forecast Suggests 27.74% Upside As of December 6, 2025, the ...
The Irish Times

Galway’s Dexcom Stadium to host Ireland’s Women’s Six Nations clash with Italy

Connacht’s renovated Dexcom Stadium will host a Women’s Six Nations fixture for the first time on Saturday, April 18th when Scott Bemand’s Ireland side will take on Italy at the Galway venue, with the ...
Morningstar

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...
Business Wire

Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...
Reuters

Dexcom beats quarterly estimates on strong demand for glucose monitors

Oct 30 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...
Newsweek

‘It’s Life-Threatening’—Dexcom G7 Users Say Glucose Monitor Is Failing Them

People with Type 1 diabetes are estimated to make up to 180 more decisions a day than someone without the disease, according to a study from Stanford University. Each meal, workout, or night’s sleep ...
Barron's

DexCom Is Doubling Down on Its ‘Mistake.’ Why It’s Time to Buy the Stock.

Sometimes the best way to fix a mistake is to double down on it—and that is just what DexCom is doing with its continuous glucose monitors for diabetes patients. It’s a decision that should pay off ...
Medscape

Dexcom Issues Recall for G7, ONE+ Apps for Software Issues

Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of unexpected sensor failures. This recall ...
The Motley Fool

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

DexCom's returns over the past decade have been solid, but not quite on par with the market's. The company has encountered some headwinds in recent years that have sunk its stock price. Despite the ...